Innovations & Investing

The most expensive problem in modern metabolic medicine may not be obesity. It may be the human stomach. Semaglutide, the...

Sometimes the most consequential medical discoveries arrive not as new drugs but as new ways of looking at familiar data....

Few areas of modern medicine have transformed as quickly—or as unpredictably—as the pharmacology of metabolic disease. For decades, obesity pharmacotherapy...

For more than a decade, incretin pharmacology has transformed the treatment landscape for obesity and type 2 diabetes. Drugs built...

Search activity surrounding remote patient monitoring platforms, reimbursable digital therapeutics, chronic disease tele-surveillance, and algorithmic triage systems has intensified across...

Search activity around concierge telehealth platforms, digital primary care memberships, hybrid virtual‑physical clinic subscriptions, and employer‑sponsored premium access models has...

Digital patient portals have transformed access to health information with a speed that would have seemed improbable a decade ago....

The exam room used to be the narrowest point in the healthcare system—the place where expertise condensed into a single...

Psilocybin, MDMA, and ketamine—substances long relegated to the margins of medicine—are advancing through clinical trials with growing institutional legitimacy. The...

Artificial intelligence systems trained on large-scale imaging and clinical datasets now rival, and in some narrow domains exceed, human diagnostic...

Cancer vaccines have reentered the policy and investment conversation with unusual persistence over the past two weeks, following reporting on...

What began as discrete point solutions — a pulse oximeter here, a hemodynamic sensor there — is becoming a latticework...